1Knapp, HR (1997) Dietary fatty acids in human thrombosis and haemostasis. Am J Clin Nutr 65, 1687S–1698S.
2Kwon, JS, Snook, JT, Wardlow, GM, et al. (1991) Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. Am J Clin Nutr 54, 341–348.
3Thijssen, MA, Hornstra, G & Mensink, RP (2005) Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J Nutr 135, 2805–2811.
4Sinclair, HM (1956) Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 270, 381–383.
5Lee, J & Hwang, DH (2007) . In Fatty Acids in Foods and Their Implications, 3rd ed., pp. 715–726Boca Raton, FL: CRC Press.
6Hornstra, G (1989) Effect of dietary lipids on platelet function and thrombosis. Ann Med 21, 53–57.
7Hornstra, G (1989) Dietary lipids, platelet function and arterial thrombosis. Wien Klin Wochenschr 101, 272–277.
8Harris, WS, Miller, M, Tighe, AP, et al. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12–24.
9Chan, JK, McDonald, BE, Gerrard, JM, et al. (1993) Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 28, 811–817.
10Sánchez-Muniz, FJ, Oubiña, P, Benedí, J, et al. (1998) Preliminary study platelet aggregation in postmenopausal women consuming extra virgin olive oil and high oleic acid sunflower oil. J Am Oil Chem Soc 75, 217–223.
11Oubiña, P, Sanchez-Muniz, FJ, Ródenas, S, et al. (2001) Eicosanoid production, thrombogenic ratio, and serum and LDL-peroxides in normo and hypercholesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components. Br J Nutr 85, 41–47.
12Sánchez-Muniz, FJ, Oubiña, P, Ródenas, S, et al. (2003) Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein. Eur J Nutr 42, 299–306.
13Miller, GJ (1993) Hyperlipidaemia and hypercoagulability. Prog Lipid Res 32, 61–69.
14Gebauer, SK, Psota, TL & Harris, WS (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83, 6 Suppl., 1526S–1535S.
15Nus, M, Ruperto, M & Sánchez-Muniz, FJ (2004) Nuts, cardio and cerebrovascular risks. A Spanish perspective. Arch Latinoam Nutr 54, 137–148.
16Tapsell, LC, Gillen, LJ, Patch, CS, et al. (2004) Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27, 2777–2783.
17Anderson, KJ, Teuber, SS, Gobeille, A, et al. (2001) Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 13, 2837–2842.
18Almario, RU, Vonghavaravat, V, Wong, R, et al. (2001) Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 74, 72–79.
19Iwamoto, M, Imaizumi, K, Sato, M, et al. (2002) Serum lipid profiles in Japanese women and men during consumption of walnuts. Eur J Clin Nutr 56, 629–637.
20Feldman, EB (2002) The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 132, S1062–S1101.
21Ros, E, Nunez, I, Pérez-Heras, A, et al. (2004) A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109, 1609–1614.
22Sabate, J (1999) Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 70, 500S–503S.
25Aranceta Bartrina, J, Pérez Rodrigo, C, Ruiz Vadillo, V, et al. (2005) . In Frutos secos, salud y culturas Mediterráneas, pp. 77–96 [Salas-Salvadó, J, Ros Róala, E and Sabaté Casellas, J, editors]. Barcelona: Glosa.
26Serrano, A, Cofrades, S, Ruiz-Capillas, C, et al. (2005) Nutritional profile of restructured beef steak with added walnuts. Meat Sci 70, 647–654.
27Canales, A, Benedí, J, Nus, M, et al. (2007) Effect of walnut-enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD-risk factor. J Am Coll Nutr 26, 225–232.
28Nus, M, Frances, F, Librelotto, J, et al. (2007) Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat. J Nutr 137, 1783–1788.
29Olmedilla-Alonso, B, Granado-Lorencio, F, Herrero-Barbudo, C, et al. (2008) Comsumption of restructured meat products with added walnuts has a cholesterol-lowering effect in subjects at high cardiovascular risk: a randomised, crossover, placebo-controlled study. J Am Coll Nutr 27, 342–348.
30Basili, S, Pacini, G, Guagnano, MT, et al. (2006) Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 48, 2531–2538.
31Coban, E, Yilmaz, A & Sari, R (2007) The effect of weight loss on the mean platelet volume in obese patients. Platelets 18, 212–216.
32Vignini, A, Nanetti, L, Moroni, C, et al. (2008) Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia. Nutr Metab Cardiovasc Dis 18, 553–558.
33Moreiras, O, Carbajal, A & Cabrera, L (editors) (2007) Tablas de Composición de Alimentos. Madrid: Editorial Pirámide.
34Olmedilla Alonso, B, Granado Lorencio, F, Herrero Barbudo, C, et al. (2005) Productos cárnicos funcionales preparados con nuez. Evaluación del efecto funcional. Alimentación 24, 37–41.
35Cardinal, DC & Flower, RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3, 135–158.
36Hishinuma, T, Yu, GS, Takabatake, M, et al. (1996) Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. Prostaglandins Leukot Essent Fatty Acids 54, 445–449.
37Mensink, RP, van Houwelingen, AC, Kromhout, D, et al. (1999) A vitamin E concentrate rich in tocotrienols had not effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 69, 213–219.
38Bagchi, D, Garg, A, Krohn, RL, et al. (1997) Oxygen free radical scavenging abilities of vitamin C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95, 179–189.
39Bravo, L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317–333.
40Bagchi, D, Garg, A, Krohn, RL, et al. (1998) Protective effect of grape proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol 30, 771–776.
41Murray, M & Pizzorno, J (1999) . In The Textbook of Natural Medicine, 2nd ed., pp. 899–902 [Murray, M and Pizzorno, J, editors]. London: Churchill Livington.
42Robert, L, Godeau, G, Gavignet-Jeannin, C, et al. (1990) The effect of procyanidolic oligomers on vascular permeability. A study using quantitative morphology. Pathol Biol (Paris) 38, 608–616.
43Anfossi, G, Russo, I, Massucco, P, et al. (2004) Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity. Eur J Clin Invest 34, 482–489.
44Srivastava, KC (1985) Docosahexaenoic acid (C22:6 omega 3) and linoleic acid are anti-aggregatory, and alter arachidonic acid metabolism in human platelets. Prostaglandins Leukot Med 7, 319–327.
45Szczeklik, A, Gryglewski, RJ, Domagala, B, et al. (1985) Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 54, 425–430.
46Fine, AM (2000) Oligomeric proanthocyanidin complexes: History, structure, and phytopharmaceutical applications. Alternative Med Rev 5, 144–151.